Tumor necrosis factor (TNF)-α-stimulated gene 6 (TSG-6), the first soluble chemokine-
binding protein to be identified in mammals, inhibits chemotaxis and transendothelial …

The identification of novel targets to modulate the immune response triggered by cerebral
ischemia is crucial to promote the development of effective stroke therapeutics. Since tumour …

TNF-stimulated gene-6 (TSG-6) is a multifunctional protein secreted in response to pro-
inflammatory stimuli by a wide range of cells, including neutrophils, monocytes, and …

At present, the occurrence and development of inflammatory diseases are closely related to
the abnormal changes of the content and function of many cytokines. At the same time …

Tumor necrosis factor-(TNF) stimulated gene-6 (TSG-6) is an inflammation-associated
secreted protein that has been implicated as having important and diverse tissue protective …

Inflammation is an important factor contributing to developmental brain injury in preterm
infants. Although tumor necrosis factor-inducible gene 6 protein (TSG-6) has …

Abstract TNF-stimulated gene/protein-6 (TSG-6) is expressed by many different cell types in
response to proinflammatory cytokines and plays an important role in the protection of …

Mesenchymal stem cells (MSCs) are well established to have promising therapeutic
properties. TNF-stimulated gene-6 (TSG-6), a potent tissue-protective and anti-inflammatory …

Abstract Interleukin (IL)-33 was initially recognized as a constituent of the IL-1 cytokine
family in 2005. It exerts pleiotropic effects by regulating immune responses via its binding to …

Tumor necrosis factor (TNF)-stimulated gene-6 (TSG-6) binds to hyaluronan and can
reorganize/stabilize its structure, also enhancing the binding of this glycosaminoglycan to its …